Sulfasalazine Delayed-Release Tablets

Dosage form: tablet, delayed-release
Drug classes:5-aminosalicylates, Antirheumatics

Medically reviewed by Drugs.com. Last updated on Aug 1, 2021.

Enteric-coated Tablets

Sulfasalazine Delayed-Release Tablets Description

Sulfasalazine delayed release tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.

Sulfasalazine delayed release tablets are film coated with cellulose acetate phthalate to retard disintegration of the tablet in the stomach and reduce potential irritation of the gastric mucosa.

Therapeutic Classification: Anti-inflammatory agent and/or immunomodulatory agent.

Chemical Designation: 5-([p-(2-pyridylsulfamoyl)phenyl]azo) salicylic acid.

Chemical Structure:

Molecular Formula: C18H14N